US Patent 7268137 Ocular therapy
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+226 characters)
Article
Patent abstract
A method for treating a subject suffering from epiretinal membrane formation or retinal detachment due to epiretinal membrane formation is disclosed. The method comprises administering a compound of the formula:
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07268137 Ocular therapy US Patent 7268137 Ocular therapy
Infobox
Patent Number
0726813700
Patent Number
726813700
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072681370
Date of Patent
September 11, 2007
0Patent Application Number
107042970
Date Filed
November 7, 2003
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072681370
Date of Patent
September 11, 2007
0Patent Application Number
107042970
Date Filed
November 7, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07268137 Ocular therapy
Infobox
Is a
Patent jurisdiction
Patent number
07268137
Date of patent
September 11, 2007
Patent application number
10704297
Date Filed
November 7, 2003
Patent primary examiner
Find more entities like US Patent 7268137 Ocular therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
